— Know what they know.
Not Investment Advice

VIAP OTC

VIA Pharmaceuticals, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -94.4% 5Y: -93.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 48 · $10279 mcap · 20M float · 0.0036% daily turnover

Cash Flow Trends

Operating Cash Flow
-$6M +48.5% ▲
Capital Expenditures
$0 +100.0% ▲
Free Cash Flow
-$6M +48.6% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$763 +0.0% ▲
Net Change in Cash
-$2M -12.3% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2006FY2007FY2008FY2009FY2010
— Operating Activities —
Net Income-$9M-$22M-$20M-$21M-$10M
Depreciation & Amort.$62K$119K$206K$136K$75K
Stock-Based Comp.$0$0$1M$1M$748K
Change in Working Capital-$39K$2M-$140K$764K$966K
Other Non-Cash Items$452K$952K$14K$7M$2M
Operating Cash Flow-$8M-$19M-$19M-$12M-$6M
— Investing Activities —
Capital Expenditures-$147K-$621K-$141K-$16K$0
Acquisitions (Net)$0$0$0$0$0
Investment Purchases-$36M$0$0$0$0
Investment Sales$51M$0$0$0$0
Other Investing-$15M$11M$0$532$0
Investing Cash Flow-$147K$11M-$141K-$16K$0
— Financing Activities —
Net Debt Issuance-$115K$5M-$2K$10M$4M
Stock Repurchased$0-$6K$0$0-$763
Dividends Paid$0$0$0$0$0
Other Financing$490K$0$2K$2K$1K
Financing Cash Flow$11M$28M$229$10M$4M
Net Change in Cash$3M$20M-$19M-$2M-$2M
Cash End of Period$3M$23M$4M$2M$84K
Free Cash Flow-$8M-$20M-$19M-$12M-$6M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms